Table 3 Effects of the intervention on AL adherence measured the day after expected completion of the full 3-day course—ITT analysis in category 3
AL adherence | Control NÂ =Â 289 n (%) | Intervention NÂ =Â 273 n (%) | All patients NÂ =Â 562 n (%) | OR (95% CI) | p value |
|---|---|---|---|---|---|
All AL doses completed | 282 (97.6) | 267 (97.8) | 549 (97.7) | 1.10 (0.37–3.33) | 0.860 |
All doses timely completed | 209 (72.3) | 189 (69.2) | 398 (70.8) | 0.82 (0.56–1.19) | 0.302 |
Dose 2 | |||||
 Adherent | 222 (76.8) | 205 (75.1) | 427 (76.0) | 0.87 (0.58–1.29) | 0.479 |
Dose 3 | |||||
 Adherent | 274 (94.8) | 267 (97.8) | 541 (96.3) | 2.44 (0.93–6.37) | 0.070 |
Dose 4 | |||||
 Adherent | 271 (93.8) | 262 (96.0) | 533 (94.8) | 1.58 (0.73–3.41) | 0.242 |
Dose 5 | |||||
 Adherent | 273 (94.5) | 264 (96.7) | 537 (95.6) | 1.72 (0.75–3.96) | 0.203 |
Dose 6 | |||||
 Adherent | 256 (88.6) | 249 (91.2) | 505 (89.9) | 1.30 (0.74–2.28) | 0.355 |